GARDASIL

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Croatia, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug GARDASIL contains a combination of these active pharmaceutical ingredients (APIs):

1 L1 protein of human papillomavirus type 6 UNII 61746O90DY - HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 6

2 L1 protein of human papillomavirus type 11 UNII Z845VHQ61P - HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 11

3 L1 protein of human papillomavirus type 16 UNII 6LTE2DNX63 - HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 16

4 L1 protein of human papillomavirus type 18 UNII J2D279PEM5 - HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 18

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BM01	Papillomavirus (human types 6, 11, 16, 18)	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BM Papillomavirus vaccines
Discover more medicines within J07BM01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525503601151314
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.544-03-07
Country: EE	Ravimiamet	Identifier(s): 1260436, 1260447, 1260458, 1260469, 1260470, 1364284
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06357007, 06357008
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 108803
Country: JP	医薬品医療機器総合機構	Identifier(s): 631340TG1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028639, 1028640, 1028641, 1028642, 1028643, 1028644, 1028645, 1028646, 1028656, 1028657, 1028658, 1028659
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 81612
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12342
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100309846
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64136001
Country: SG	Health Sciences Authority	Identifier(s): 13227P, 13228P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 11193011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636950104, 8699636950128
Country: US	FDA, National Drug Code	Identifier(s): 0006-4045, 0006-4109, 50090-1523
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/30.1/0145